1. Home
  2. DFTX vs XMTR Comparison

DFTX vs XMTR Comparison

Compare DFTX & XMTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Definium Therapeutics Inc. Common Shares

DFTX

Definium Therapeutics Inc. Common Shares

SELL

Current Price

$30.21

Market Cap

5.9B

Sector

N/A

ML Signal

SELL

Logo Xometry Inc.

XMTR

Xometry Inc.

N/A

Current Price

$121.80

Market Cap

5.8B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
DFTX
XMTR
Founded
N/A
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
5.8B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
DFTX
XMTR
Price
$30.21
$121.80
Analyst Decision
Strong Buy
Buy
Analyst Count
19
12
Target Price
$72.83
★ $125.55
AVG Volume (30 Days)
★ 1.5M
812.3K
Earning Date
11-09-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 26.95
EPS
N/A
★ N/A
Revenue
N/A
★ $686,631,000.00
Revenue This Year
N/A
$37.31
Revenue Next Year
N/A
$22.81
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 25.87
52 Week Low
$14.62
$35.86
52 Week High
$49.70
$127.49

Technical Indicators

Market Signals
Indicator
DFTX
XMTR
Relative Strength Index (RSI) 37.55 65.13
Support Level $20.43 $83.30
Resistance Level $38.59 N/A
Average True Range (ATR) 2.10 9.34
MACD -0.21 1.91
Stochastic Oscillator 3.34 86.19

Price Performance

Historical Comparison
DFTX
XMTR

About DFTX Definium Therapeutics Inc. Common Shares

Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform.

About XMTR Xometry Inc.

Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.

Share on Social Networks: